Filter By “Lab / Genomic Data”

As the first 20 years of the genomic revolution come to a close, we are taking a step back to ask “how far have we come?” and “where is genomic innovation taking us?” 

A large biopharmaceutical client conducted a Phase II, 6-week, randomized, placebo-controlled, dose-finding trial to evaluate the efficacy, tolerability and safety of a new oral medication in patients with major depressive disorder who were not responding to antidepressant therapy.

A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC).

Despite high effectiveness of COVID-19 vaccines in the real-world, there have been cases of fully vaccinated patients contracting COVID.

When it comes to building the ideal patient cohort, the breadth and variety of demographic and clinical criteria available to select from is critical.etc...